Intelligence / Healthtech / New Clinical Trials / AstraZeneca
AstraZeneca
2 Nov 2026: Trial registered · A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 2 Nov 2026
- Title
- A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234
- Conditions
- Healthy Participants
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Countries
- United Kingdom
- Country
- United Kingdom
- Reference
- NCT07911514
- Location
- United Kingdom
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Find the decision makers at AstraZeneca
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for AstraZeneca in our registers.
More from United Kingdom
New Clinical Trials
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.